US Trade Body Bats For Ethylene-Treated Spices Amid Heat On Indian Firms
The American Spice Trade Association has asserted that ethylene oxide is permitted for use on spices in the US and prohibiting it could potentially result in "serious unintended implications," like non-compliance with food safety standards.
The comments come at a time when Hong Kong suspended sales of certain ready-made spices from MDH and Everest, considered household brands in India, for allegedly containing high levels of cancer-causing ethylene oxide. This sparked concerns regarding food safety regulations, with several countries like the US, New Zealand, the Maldives, Bangladesh and Australia raising questions about the quality of spices supplied from India.
"Currently, the US regulations permit the use of EtO treatment on imported spice products as long as residues adhere to the prescribed tolerances," Laura Shumow, executive director of ASTA, said in a letter dated May 9 to the Spices Board of India. "Moreover, without the use of EtO, imported spices are at a higher risk of the presence of pathogens and non-compliance with the FDA food safety regulations."
The US imports more than 1 lakh tonnes of spices from India valued at more than $360 million annually, according to the trade body. The ASTA represents 200 spice manufacturers in the US.
Ethylene oxide is an approved antimicrobial fumigant and the maximum residue limit for EtO is 7 parts per million, while that of ethylene chlorohydrin is 940 ppm for herbs and spices, except basil, the industry body said. The spice industry relies on EtO sterilisation as one of the "primary methods" to comply with Food and Drug Administration regulations under the Food Safety Modernization Act.
"Specifically, the Preventive Controls for Human Foods Final Rule requires that US companies have in place a validated kill step to control the risk of foodborne pathogens known to occur on spices, including salmonella and E. coli," it said. The US Environmental Protection Agency determines that consumption of spices treated with EtO is "safe," while the FDA has indicated that there is no "cancer concern" from exposures to EtO residues from the consumption of spices.
Imports, too, are required to be treated with a validated kill step, such as EtO, prior to being sold in the US. Spices that do not undergo a validated kill step prior to import to the US will be deemed 'not ready to eat' and are required to be labelled with a disclosure of 'not processed to control microbial hazards', according to the ASTA. "Replacing EtO with alternative methods would require cost-and time-intensive validation studies to comply with FDA regulations while maintaining quality standards."
Both Everest and MDH had previously said their spices were "safe" for consumption. The Food Safety and Standards Authority of India is currently checking the quality standards of the two companies. Its scientific panel examining the matter is expected to submit a detailed report on May 31.
The Spices Board of India, the government's regulator for spice exports, said it was working with the companies to find the "root cause" of the alleged contamination as inspections started at their plants. It also issued guidelines to exporters, advising them against using EtO as a sterilising agent to reduce the microbial contamination in spice consignments. It suggested switching to alternatives like steam sterilisation and irradiation.
A report by the Global Trade Research Initiative has warned that rising global scrutiny could jeopardise over half of India's $4 billion in spice exports, particularly if other countries implement bans or restrictions similar to those imposed by Hong Kong and Singapore. If the European Union and China—influenced by actions in Hong Kong and Singapore—decide to reject Indian spice consignments over quality issues, Indian spice exports could see a "dramatic downturn," the think tank had said.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.